FDA pulls preterm-birth drug Makena and its generics from market after 12 years

The drug, which was approved using an accelerated pathway in 2011, showed no clinical benefit in a later trial.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.